iSpeechPathology.com – Call us: 800-242-5183
Austill's Educational Therapy Services - Voice - November 2025

Forget Me Not...Evaluation and Treatment of the Patient with Dementia, Part 1: Who, What and Why

Forget Me Not...Evaluation and Treatment of the Patient with Dementia, Part 1: Who, What and Why
Amber B. Heape, CScD, CCC-SLP, FNAP
April 6, 2016
Share:

Today, we will begin with the basics of dementia -- the who, what and why. We will classify dementia into types and look at the difference between reversible and irreversible dementia. We will distinguish the stages of dementia and outline risk factors to determine potential for cognitive decline in patients. In the upcoming three sessions of this series, we will delve into more in-depth information.

The aging population is one of the fastest growing populations in the United States. In 2013, the US Administration on Aging reported that one in every seven Americans could be classified as “elderly” (age 65 and older). At that time, they estimated that there were 45 million living Americans who could be categorized as elderly. By 2060, that number is projected to double to over 98 million.

Science and modern medicine has enabled the life span to increase. As the aging population grows, so does the number of people living with dementia and Alzheimer’s. In 2015, the Alzheimer's Association indicated that there were 5.1 million people over age 65 in the United States living with Alzheimer's Dementia. One out of nine people over 65 have Alzheimer’s disease. At age 85, that number increases to one in three (about 33%) who have Alzheimer's disease.

The World Health Organization reports that every 4 seconds, a new case of dementia is diagnosed. To illustrate, during this 90-minute course, 1350 new cases of dementia will be diagnosed; 7.7 million new cases worldwide every single year. It is the number one cause of disability and dependency in older adults. In 2010, the cost of dementia worldwide was estimated at $604 billion.

Dementia Defined

Although we often refer to dementia like it is a disease, it is important to clarify that dementia itself is not a specific disease -- it is a group of symptoms. Before we go any further, it is necessary to make that distinction between disease versus symptoms. To have a diagnosis of dementia, there needs to be a loss of function in at least two of the following five areas: language, judgment, memory, spatial ability or visual ability. There are also two primary categories of dementia that we will discuss: reversible and non-reversible.

Reversible Dementias

In many circumstances, dementia is reversible. I learned a mnemonic device during my certified dementia practitioner course to remember the different situations where dementia may be reversed, and it spells d-e-m-e-n-t-i-a. 

  • D - drug reaction, overdose, toxicity 
  • E - emotional disorders (depression) 
  • M - metabolic or endocrine (thyroid) issues 
  • E - eyes and ears (sensory loss) 
  • N - nutritional deficits 
  • T - tumors 
  • I - infection (sepsis, UTI, pneumonia) 
  • A - arteriosclerosis

Drug reactions, overdoses, or drug toxicity can cause dementia which may be reversed. Commonly, elders who are on multiple medications are at risk of poly-pharmaceutical side effects because of the number of medications they take. Emotional disorders, especially depression, can lead to symptoms of dementia which may be reversible. Metabolic and endocrine or thyroid issues can also lead to reversible dementias. Deafness, blindness or a decrease in either one of those sensory areas can cause symptoms of dementia. Nutritional deficits, and also tumors (whether cancerous or benign) can cause dementia symptoms. Infection is probably the most common cause that I witness in my practice with elderly population. Infections in the elderly (e.g., sepsis, UTI, pneumonia, gangrene) tend to cause sudden cognitive decline or sudden symptoms of dementia. Lastly, arteriosclerosis or coronary artery disease also may cause some reversible type dementias.

Non-Progressive Dementias

Traumatic brain injury can be categorized as non-progressive dementia, because it is an acute injury. It does not progress after that initial phase of TBI. Anoxia (lack of oxygen or respiratory distress) can cause non-progressive dementia that will not necessarily worsen over a long period of time. Finally, vascular dementia from a single CVA would not be considered progressive. We will discuss other types of vascular dementias a bit further along in this session.

Progressive Dementias

We refer to progressive dementias as non-reversible. However, later on in the series, I will address the fact that non-reversible does not necessarily mean non-rehabilitative. There are treatments and practices that have proven useful in patients exhibiting these dementias and symptoms. I will outline those rehabilitative practices in upcoming courses.

Non-reversible or progressive dementias include the following: 

  • Parkinson’s 
  • Multi-infarct or vascular dementias
  • Fronto-temporal 
  • Lewy Body 
  • Huntington’s Disease or Huntington’s Chorea 
  • Creutzfeldt-Jakob 
  • Korsakoff Syndrome 
  • Alzheimer's disease

Parkinson’s Disease (PD) Related Dementia

Over 50%, and as high as 80%, of people with Parkinson’s disease will experience dementia at some point during that disease process. The number one trigger for the development of PD-related dementia is stress. Typically, the timeframe between the original Parkinson’s diagnosis and the onset of Parkinson’s related dementia, is approximately a decade. Neuro-hallmarks (brain-related issues) that indicate Parkinson’s-related dementia are beta-amyloid plaques and tangles. We will discuss those in more detail later.


amber b heape

Amber B. Heape, CScD, CCC-SLP, FNAP

Amber Heape, CScD, CCC-SLP, FNAP, is an Assistant Professor and Director of the Health Professions Education Track in the SLPD program at Rocky Mountain University. Dr. Heape also teaches adult medical coursework at South Carolina State University. She serves in multiple volunteer committees at the state and national levels. She is a Fellow of the National Academies of Practice, a Certified Dementia Practitioner, and teaches interdisciplinary/multidisciplinary courses related to healthcare in the geriatric population.  She is also Coordinator for SIG 15 (Gerontology) and an ASHA Leadership Development Porgram graduate.  Dr. Heape has a passion for clinical education and mentoring future leaders. 



Related Courses

Social Isolation and COVID-19 Cognitive Decline: From Zero to Hero!
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video
Course: #9514Level: Intermediate1 Hour
Social distancing and isolation associated with the COVID-10 pandemic have begun to take a toll on patients in residential settings, but SLPs can help mitigate the long-term consequences. This course discusses the risk factors for and effects of isolation, as well as potential strategies to prevent or reverse pandemic-related cognitive decline.

Rebuilding the Bridge: Post-Pandemic Mentorship for Future SLPs
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Live WebinarTue, Dec 16, 2025 at 3:00 pm EST
Course: #11278Level: Intermediate1 Hour
The COVID-19 pandemic disrupted traditional clinical training pathways, leaving many Clinical Fellows and graduate students entering the field with unique challenges and gaps in experience. This course discusses equipping seasoned SLPs with practical, evidence-based strategies to mentor, support, and empower the next generation of clinicians. The course explores real-world scenarios and actionable tools to rebuild confidence, competence, and connection in a post-pandemic professional landscape.

Ethical Practice in Aging Care
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video
Course: #8755Level: Introductory1 Hour
As healthcare and reimbursement are changing, therapists often find themselves facing questions of ethics when working with clients who are aging. This course will review the principles of bioethics and how they apply to SLPs working with aging adults. Decision-making scenarios will be presented and discussed for application of knowledge.

Navigating Bioethics in a Rapidly Evolving Health Landscape
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video
Course: #11355Level: Introductory1 Hour
As healthcare continues to evolve, ethical challenges emerge that require critical thought and application of bioethical principles. This course explores the foundational concepts of bioethics, focusing on current issues such as telehealth, resource allocation, and patient confidentiality in clinical settings. The course provides participants with practical tools to navigate ethical dilemmas and apply bioethical decision-making to ensure patient-centered, professional care in today’s dynamic health climate.

Dysphagia MythBusters: Tackling the Truths About Patient Choice in Residential Care Settings
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video
Course: #10077Level: Intermediate1 Hour
Are your residential care patients with dysphagia “non-compliant” with their diets? This course provides a deep dive into a patient-centered approach to dysphagia care that also supports safety. Myths and facts surrounding patient choice are identified, and appropriate courses of action for the SLP are discussed.